Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Meta-analysia of combining rh-endostatin with chemotherapy in treatment of patients with nsclc

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: CHEN, Baicheng (The 303 Hospital of PLA, China, Nanning, China)
  • Co-author(s): Zhang, Qi (The 303 Hospital of PLA, China, NANNING, China)
    Xia, Aijun (The 303 Hospital of PLA, China, NANNING, China)
  • Abstract:

    Objective In order to evaluate the efficacy of combining rh-endostatin with Chemo- therapy for non-small cell lung cancer(NSCLC) compared with chemotherapy alone. Methods The randomized clinical trials(RCTs) that compared the efficacy of combining rh-endostatin with Chemotherapy and chemotherapy alone form 2000 to 2004. A meta-analysis was..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses